Bank-Of-New-York-Mellon

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
20,557
Total Value
248488795961
Accession Number
0001390777-25-000071
Form Type
13F-HR
Manager Name
Bank-Of-New-York-Mellon
Data Enrichment
92% identified
18,855 identified1,702 unidentified

Holdings

20,557 positions • $248.5B total value
Manager:
Search and click to pin securities to the top
Page 198 of 205
HilleVax, Inc.
Shares:—
Value:$105.4K
% of Portfolio:0.0% ($105.4K/$248.5B)
Actinium Pharmaceuticals, Inc.
Shares:—
Value:$105.1K
% of Portfolio:0.0% ($105.1K/$248.5B)
LEE ENTERPRISES, Inc
Shares:—
Value:$105.0K
% of Portfolio:0.0% ($105.0K/$248.5B)
464287663
Shares:—
Value:$104.8K
% of Portfolio:0.0% ($104.8K/$248.5B)
Caesarstone Ltd.
Shares:—
Value:$104.5K
% of Portfolio:0.0% ($104.5K/$248.5B)
WOODSIDE ENERGY GROUP LTD
Shares:—
Value:$104.4K
% of Portfolio:0.0% ($104.4K/$248.5B)
XAI Madison Equity Premium Income Fund
Shares:—
Value:$103.5K
% of Portfolio:0.0% ($103.5K/$248.5B)
VirTra, Inc
Shares:—
Value:$102.9K
% of Portfolio:0.0% ($102.9K/$248.5B)
Purple Innovation, Inc.
Shares:—
Value:$102.5K
% of Portfolio:0.0% ($102.5K/$248.5B)
78464A631
Shares:—
Value:$102.0K
% of Portfolio:0.0% ($102.0K/$248.5B)
LANTRONIX INC
Shares:—
Value:$101.8K
% of Portfolio:0.0% ($101.8K/$248.5B)
Artiva Biotherapeutics, Inc.
Shares:—
Value:$99.9K
% of Portfolio:0.0% ($99.9K/$248.5B)
Acumen Pharmaceuticals, Inc.
Shares:—
Value:$99.3K
% of Portfolio:0.0% ($99.3K/$248.5B)
46641Q191
Shares:—
Value:$98.7K
% of Portfolio:0.0% ($98.7K/$248.5B)
Invivyd, Inc.
Shares:—
Value:$97.6K
% of Portfolio:0.0% ($97.6K/$248.5B)
294628102
Shares:—
Value:$95.9K
% of Portfolio:0.0% ($95.9K/$248.5B)
Kyverna Therapeutics, Inc.
Shares:—
Value:$94.2K
% of Portfolio:0.0% ($94.2K/$248.5B)
TPI COMPOSITES, INC
Shares:—
Value:$93.9K
% of Portfolio:0.0% ($93.9K/$248.5B)
Lantern Pharma Inc.
Shares:—
Value:$93.7K
% of Portfolio:0.0% ($93.7K/$248.5B)
Clipper Realty Inc.
Shares:—
Value:$92.8K
% of Portfolio:0.0% ($92.8K/$248.5B)